AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 100 filers reported holding AVROBIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $973,000 | -41.1% | 109,460 | -16.0% | 0.00% | -50.0% |
| Q1 2021 | $1,653,000 | +20.3% | 130,270 | +32.2% | 0.00% | 0.0% |
| Q4 2020 | $1,374,000 | -9.4% | 98,550 | -15.3% | 0.00% | 0.0% |
| Q3 2020 | $1,516,000 | -44.1% | 116,420 | -25.1% | 0.00% | -50.0% |
| Q2 2020 | $2,713,000 | -80.0% | 155,503 | -82.1% | 0.00% | -63.6% |
| Q1 2020 | $13,532,000 | +61.0% | 869,666 | +108.3% | 0.01% | +10.0% |
| Q4 2019 | $8,405,000 | +23.9% | 417,549 | -13.1% | 0.01% | +11.1% |
| Q3 2019 | $6,784,000 | +268.9% | 480,429 | +324.9% | 0.01% | +125.0% |
| Q2 2019 | $1,839,000 | -39.0% | 113,071 | -17.3% | 0.00% | -42.9% |
| Q1 2019 | $3,016,000 | +6183.3% | 136,761 | +4614.3% | 0.01% | – |
| Q4 2018 | $48,000 | -73.2% | 2,901 | -16.0% | 0.00% | – |
| Q3 2018 | $179,000 | +108.1% | 3,454 | +15.1% | 0.00% | – |
| Q2 2018 | $86,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,930,704 | $42,572,000 | 24.97% |
| Aisling Capital Management LP | 811,998 | $17,905,000 | 13.64% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $4,753,000 | 1.30% |
| Eventide Asset Management | 928,891 | $20,482,000 | 0.70% |
| EMERALD ADVISERS, LLC | 614,408 | $13,548,000 | 0.55% |
| Virtus ETF Advisers LLC | 10,850 | $239,000 | 0.51% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 522,590 | $11,523,000 | 0.46% |
| Cormorant Asset Management, LP | 300,000 | $6,615,000 | 0.45% |
| Blackstone Inc. | 2,962,325 | $65,319,000 | 0.32% |
| FARALLON CAPITAL MANAGEMENT LLC | 900,000 | $19,845,000 | 0.15% |